who created tirzepatide Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond Being real with y’all ✨

When everything is working as it should, antioxidants like glutathione stop free radicals in their tracks before they can wreak havoc on healthy cells

Your skin feels tender, almost like a mild sunburn, or perhaps it tingles when your clothing brushes against your arm

The true risk for those who did not experience a vascular event is not addressed

Tirzepatide is a dual GLP-1 and GIP receptor agonist, which is part of why SURMOUNT-1 participants lost more weight on average than STEP 1 participants lost on semaglutide, though the two trials were not run head-to-head in the same population

Even so, the convergence of large-scale human data and mechanistic animal studies puts epilepsy on the map as a promising new use for GLP-1 receptor agonists

This dual-action medication, paired with expert guidance, makes achieving sustainable weight loss within your reach